[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO, President & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter M. Stazzone", "age": 73, "title": "Chief Financial Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.05, "open": 4.14, "dayLow": 3.98, "dayHigh": 4.14, "regularMarketPreviousClose": 4.05, "regularMarketOpen": 4.14, "regularMarketDayLow": 3.98, "regularMarketDayHigh": 4.14, "payoutRatio": 0.0, "beta": 0.894, "volume": 37991, "regularMarketVolume": 37991, "averageVolume": 102387, "averageVolume10days": 92780, "averageDailyVolume10Day": 92780, "bid": 3.78, "ask": 4.34, "bidSize": 1, "askSize": 1, "marketCap": 32572524, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 6.26, "allTimeHigh": 110.4, "allTimeLow": 0.64, "fiftyDayAverage": 4.245, "twoHundredDayAverage": 3.11345, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22881580, "profitMargins": 0.0, "floatShares": 5693191, "sharesOutstanding": 8003077, "sharesShort": 127474, "sharesShortPriorMonth": 97208, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.017, "heldPercentInsiders": 0.00929, "heldPercentInstitutions": 0.09797, "shortRatio": 1.4, "shortPercentOfFloat": 0.0171, "impliedSharesOutstanding": 8003077, "bookValue": 0.414, "priceToBook": 9.830918, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -4133687, "trailingEps": -1.19, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.0250001, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 4.07, "recommendationKey": "none", "totalCash": 2887874, "totalCashPerShare": 0.506, "totalDebt": 0, "quickRatio": 5.538, "currentRatio": 10.421, "returnOnAssets": -0.68318003, "returnOnEquity": -1.30059, "freeCashflow": -3476484, "operatingCashflow": -2581395, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": 0.0, "postMarketPrice": 4.07, "postMarketChange": 0.0, "regularMarketChange": 0.02, "regularMarketDayRange": "3.98 - 4.14", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 102387, "fiftyTwoWeekLowChange": 3.4300003, "fiftyTwoWeekLowChangePercent": 5.3593755, "fiftyTwoWeekRange": "0.64 - 6.26", "fiftyTwoWeekHighChange": -2.19, "fiftyTwoWeekHighChangePercent": -0.34984025, "fiftyTwoWeekChangePercent": 102.50001, "dividendDate": 1605830400, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "fiftyDayAverageChange": -0.17499971, "fiftyDayAverageChangePercent": -0.041224904, "regularMarketChangePercent": 0.493827, "regularMarketPrice": 4.07, "marketState": "CLOSED", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "twoHundredDayAverageChange": 0.9565501, "twoHundredDayAverageChangePercent": 0.30723158, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1766783404, "regularMarketTime": 1766782801, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]